GENE ONLINE|News &
Opinion
Blog

In-Depth
Special ESG
Governmental Action for a Better Future
2023-04-17
Interviews iPSC
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
Interviews Oncology
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Special ESG
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
Special iPSC
Industrializing iPSC and Harnessing its Medical Applications – An Interview with Dr. Hong-Lin Su
2023-03-06
Special mRNA
A New Phase in Drug Development: Programming the Genome
2023-03-02
Special mRNA
Moving Beyond COVID With mRNA Technology
2023-01-18
Special Real World Evidence
2023 Trend Forecast: Transforming Healthcare with Real-world Data and Personalized Medicine
2023-01-05
Special Aduhelm
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
Special American Society of Hematology
64th ASH Annual Meeting and Exposition: Standard Treatments Face Challenges
2022-12-29
Special Biologics
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
In-Depth AI Drug
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23Partner
Special American Healthcare
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
Special Illumina
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
2022-11-17Partner
Special Opioid
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
1 2 3 … 10
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top